Download FREE Sample
Table of Contents
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Market Forecasting
- Executive Summary
- Market Overview
-
- Market Dynamics
- Drivers
- Restraints
- Key Market Trends
- Industry Speaks
- Market Dynamics
- Key Revenue Pockets
- Global Extracorporeal Membrane Oxygenation (ECMO) Market - Size & Forecast (2021-2028), By Component Type
- Hearing Devices
- Pumps
- Oxygenator
- Controllers
- Cannula
- Accessories
- Hearing Devices
- Global Extracorporeal Membrane Oxygenation (ECMO) Market - Size & Forecast (2021-2028), By Modality Type
- Veno-Arterial
- Veno-Venous
- Arterio-Venous
- Global Extracorporeal Membrane Oxygenation (ECMO) Market - Size & Forecast (2021-2028), By Patient Type
- Neonates
- Pediatric
- Adult
- Global Extracorporeal Membrane Oxygenation (ECMO) Market - Size & Forecast (2021-2028), By Region
- North America (U.S. & Canada)
- Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
- Asia Pacific (China, India, Japan, Rest of Asia Pacific)
- Rest of the World (Latin America, Middle East & Africa)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Competitive Positioning of Key Players (2022)
- Offerings Assessment, By Player
- Key Strategies Assessment, By Player (2021-2023)
- New Product & Service Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Key Companies Scanned (Indicative List)
- Fresenius Medical Care AG & Co. KGaA
- Getinge Group
- Medtronic plc
- LivaNova plc
- Abiomed, Inc. (a Johnson & Johnson business)
- Terumo Corporation
- EUROSETS
- Braile Biomdica
- MicroPort Scientific Corporation
- Other Prominent Players
